27 Ottobre 2023 

webinar

President: Paolo Marchetti, Daniele Santini

In the last years the HER 2 positive disease has undergone a real revolution. The landscape has been radically changed with the advent of new therapeutic strategy. If on one side this represents a great opportunity for cancer patients, on the other hand detect the comparison with novel toxicity profiles. The knowledge of the biological mechanisms underlying of this tumour type plays acrucial role to identify the best therapeutic path for cancer patients.In this course, opinion leaders of undisputed prestige provide a moment of scientific development and constructive dialogue able to ensure an event of high impact.

Segreteria Scientifica: Andrea Botticelli Agnese Fabbri, Giuliana D’Auria, Simone Scagnoli, Simona Pisegna

Crediti Formativi: A questo evento sono stati attribuiti n. 3 crediti ECM Provider ECM n. 3 – Rif. Evento n. 391851

Obiettivo formativo: Documentazione clinica, percorsi clinico-assistenziali diagnostici e riabilitativi, profili di assistenza, profili di cura

Professione: Medico Chirurgo

Discipline: Dermatologia e Venerologia, Oncologia, Chirurgia Generale,Ginecologia e Ostetricia

Provider: Didactika S.r.l. – Piazza della Trasfigurazione, 8/a – 00151 Roma Tel. e fax: 06 94378432 – Email: info@didactika.it